Curated News:

Medical Meetings

Add to Favorites Subscribe Share
fbshare-Medical Meetings

Showing results

110 of 3619

Article ID: 712942

Using Nitric Oxide in Medicinal Strategies Optimizes Replacing, Engineering or Regenerating Human Cells

Nathan Bryan, Ph.D.

More than one million stem cell treatments have been conducted in the United States during the past ten years. Physicians and other healthcare providers are beginning to realize regenerative medicine is the future of medicine; however major health issues remain unanswered. Dr. Nathan Bryan, one the country’s leading experts in the mechanism of nitric oxide, will tell more than seven thousand physicians attending the 27th Annual Spring Conference of the American Academy of Anti-Aging Medicine on Saturday that “the ability to use our own cells to heal our own body make good medical sense.

Released:
17-May-2019 2:40 PM EDT
Embargo will expire:
21-May-2019 6:00 PM EDT
Released to reporters:
17-May-2019 8:50 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-May-2019 6:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-May-2019 3:00 PM EDT
Released to reporters:
16-May-2019 5:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2019 3:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-May-2019 3:45 PM EDT
Released to reporters:
16-May-2019 5:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2019 3:45 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Singhimage.jpg
  • Embargo expired:
    16-May-2019 4:30 PM EDT

Article ID: 712672

Ultrasound Used To Trigger Insulin Release in Mice Shows Promise for Future Diabetes Therapy

Acoustical Society of America (ASA)

Current treatments of Type 2 diabetes can help the body use insulin at various stages of the disease, but they can also be expensive and subject patients to lifelong medication regimens and side effects. Thanks to new therapeutic ultrasound technology, one promising alternative looks to reshape how early Type 2 diabetes is managed. A group of researchers has used ultrasound therapy to stimulate insulin release from mice on demand. The team will present their findings at the 177th ASA Meeting, May 13-17.

Released:
10-May-2019 11:20 AM EDT
YawkeyBuilding.jpg

Article ID: 713044

Dana-Farber researchers present findings in more than 70 research studies at ASCO annual meeting 2019

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers are presenting more than 70 research studies at the 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31st- June 4th. ASCO is the world’s largest clinical cancer research meeting, attracting more than 30,000 oncology professionals from around the world.

Released:
16-May-2019 3:05 PM EDT
Embargo will expire:
20-May-2019 3:15 PM EDT
Released to reporters:
16-May-2019 8:35 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2019 3:15 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

NYULangoneHealthLogo.jpg
  • Embargo expired:
    15-May-2019 5:00 PM EDT

Article ID: 712868

Blood Test Can Measure Effectiveness of Treatments for Aggressive Skin Cancers

NYU Langone Health

Blood tests that track the amount of tumor DNA can ― after only one month of drug therapy ― detect how well treatment is working in patients with skin cancer, a new study finds.

Released:
14-May-2019 3:05 PM EDT
SAEM.jpg

Article ID: 712959

SAEM 2019: Gun Safety, Over Testing and More

Michigan Medicine - University of Michigan

Michigan Medicine experts highlighted new research during the keynote address and plenary session at the annual Society for Academic Emergency Medicine Annual Meeting.

Released:
15-May-2019 4:00 PM EDT

Showing results

110 of 3619

Chat now!